This site is intended for healthcare professionals
News

Phase III EDPC003R01 trial of Vascepa meets primary endpoint in patients with very high triglycerides.- Amarin Corp

Read time: 1 mins
Last updated:21th Nov 2020
Published:21th Nov 2020
Condition: Hypertriglyceridemia
Type: drug
Register free for full access to medthority.com